| Hint | Answer | Extra |
| Mouse mAb | |
| Inhibits purine synthesis | |
| Inhibits DHFR, lowers purine levels | |
| Virus that inhibits proteasomal activity and removes class I MHC molecules from the ER | |
| Microbe that inhibits phagolysosome fusion | |
| Chimeric anti-TNF monoclonal antibody | |
| Immunosuppressant that inhibits T-independent B cell activation | |
| Lose depot and stranger signals/adjuvant effect in this type of vaccine | |
| Anti-TNF with chimeric receptor | |
| Anti-CD20 chimeric monoclonal antibody | |
| Inhibits calcineurin and prevents NFAT migration to the nucleus by binding cyclophilin | |
| Recombinant fully human TNF-a receptor mAb that has ligand-binding portion fused to IgG | |
| Inhibits IL-10 synthesis, good for tx EBV | |
| Microbe that moves from cell to cell without going extracellular | |
| Metabolite of cyclophosphamide that has a toxicity damaging bladder mucosa | |
| Monoclonal antibody indicated for B lymphomas | |
| Virus that blocks effector cell activation and produces soluble IL-1 or IFN-y receptors | |
| Capsular polysaccharide inhibits phagocytosis | |
| When producing monoclonal antibodies, the fusion partner is a tumor B cell lacking what enzyme? | |
| Lowers pyrimidine nucleotide levels | |
| SAP protein in XLP cannot bind this molecule | |
| Tx of methotrexate toxicity | |